Page last updated: 2024-08-16

temozolomide and wp1066

temozolomide has been researched along with wp1066 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, Z; Chen, L; Han, L; Jiang, T; Kang, C; Li, S; Liu, Y; Shi, Z; Wang, Y; Yan, W; Yang, P; You, G; Zhang, W	1

Other Studies

1 other study(ies) available for temozolomide and wp1066

Article	Year
Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways. Oncology reports, 2011, Volume: 26, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Disease-Free Survival; Drug Synergism; Female; Glioblastoma; Humans; Immunohistochemistry; Male; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Retrospective Studies; Signal Transduction; STAT3 Transcription Factor; Temozolomide; Tyrphostins; Young Adult	2011

Article

Year

Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.

Oncology reports, 2011, Volume: 26, Issue:5

Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Disease-Free Survival; Drug Synergism; Female; Glioblastoma; Humans; Immunohistochemistry; Male; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Retrospective Studies; Signal Transduction; STAT3 Transcription Factor; Temozolomide; Tyrphostins; Young Adult

2011